Tech Company Financing Transactions
Cocrystal Discovery Funding Round
On 9/15/2011, Cocrystal Discovery raised $7.5 million in funding from Teva Pharmaceutical Industries.
Transaction Overview
Company Name
Announced On
9/15/2011
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Undisclosed
Investors
Teva Pharmaceutical Industries (Roger Kornberg)
Proceeds Purpose
This investment will be utilized by CDI to continue its development program of novel antiviral drugs that target viral replication enzymes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
19805 North Creek Pkwy.
Bothell, WA 98011
USA
Bothell, WA 98011
USA
Phone
Website
Email Address
Overview
Cocrystal Discovery, Inc. is a privately funded biotechnology company developing antiviral therapeutics for human diseases. Cocrystal has breakthrough technologies that enable the creation of first- and best-in-class antivirals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gary Wilcox
Chief Scientific Officer
Roger Kornberg
President
Sam Lee
Browse more venture capital transactions:
Prev: 9/15/2011: Roambi venture capital transaction
Next: 9/15/2011: LiveIntent venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs